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   A fundamental study was performed about alkaline phosphatase （orthophosphoric monoester
phosphohydrorase （E．C．， 3．1．3．1．） activity and its isczyme patterns in 4 normal renal tissues， 24 renal
cell carcinoma tissues and sera from patients with the tumor． The results obtained were as follows．
    1） Alkaline phcsphatasc activity in four normal renal tissues was rather consistent and the iso－
zyme pattern in polyacrylamide gel disk electrophoresis consisted of 3 or 4 components．
   2） Alkaline phcsphatase was not detected from renal cell carcinoma tissue in three cases． The
other twenty－one had the activity ofvarious degrees． The activity was rather high in well differentiated
renal cell carcinoma corn1）aired with poorly differentiated ones， although the difference was not sta－
tistically signi丘cant． With respect to the celI type， i．e． clear， granular or mixed c『ll type，’there was
no correlation with the activity of the enzyme．
   3） Renal cell carcinoma tissue was found to contain at least a component of alkaline phosphatase
isozymes of kidney proper except a case with bone type and twg cases with liver type alkaline pho－
sphatase． ln addition to this， several other isozymes were detected including Kasahara isozyme，
fetal intestinal type alkaline phosphatase and two isozymes of unknown characteristics．
   4） lncluding 3 cases with elevated serum alkaline phosphatase activity without any evidence
of liver or bone metastasis， serum alkaline phosphatase isozyme in renal cell carcinoma patients was
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regarded as the liver type．
  These resu工ts rendered it diMcult to support the modern concept of histogenesis of renal ccll car－
cinoma stating that this carcinoma is developed exclusively from the proximal convoluted tubules．
Further investigations will be needed for the establishment of this concept． The elevated serum alka－
line phosphatase in patients with renal cell carcinoma was thought to be mainly hepatic origin as
described by several authors．
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Patient profiles， serum Al． P－ase activity， histopathoJogical
findings and Al． P－ase activity in renal cgll carcinoma tissue．
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Elevated serum Al．P．ase without any evidence of liver or
bone metastasis．
SEGad． i2EI gi．blaSoed On the criteria advocated by skinner．
c＝ clear cell t二YPer m＝mixed cell type， 9＝ granularcell type






Nuclei are indiistinguishable from those of
normal tubular cells．
Nuclei are often pyknotic and slightly
irregular in shape， but only slightly enlarged
and wit二hout abnormal nuc！eQli．
Nuclei are moderately enlargedi irregu！ar and
pleomorphic． and often with large nucleoli，
but there are no bizarre forrns．
Bizarre and giant nuclei are numerous．
 C．組織Al． P－aseの抽出














 Higashino et aLIDの方法により測定したが，その概
略は次のようなものである．20mM disodium phenyl
phosphate，4mM 4－aminoantipyrineおよび2mM
MgC12を含む0．2 M carbonate－bicarbonate buffer，
pH lO．0， l mlに適量の酵素を加えて全量を2mlと
し，37℃にて15分間保温する．これに6mM K3Fe


































































 C．DEAE cellulosc カラムクロマトグラフィーに














Table 3． Al． P－ase activity in normal renal tissue．
Material
EnzymeCrude homogenate 30－70g acetone fraction
（mu／g．wet weight） （mu／mg．protein）
Normal kidney No．l
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Fig． 1．Isozyme pattern of normal renal tissue Al． P－ase








Fig． 2． lsozyme pattern of normal renal tissue AL
    P－ase cn polyacry］amide disk electrophore－
    sis． Three out of four normal renal tissue
    Al． P－ase preparation are presented．
    P： Band visible because of contaminatien
     of pigmnet in the enzyme preparation．
    Ki， K2， K3， K4．： Normal renal tissue AL









Fig． 3． lsolaticn of K4 cornpcnent by DEAE cellu－
   lose column chromatography．
    1： normal renal tissue Al． P－ase．






















Table 4． Thermostability and effect of some inhibitors on Al． P－ase of
         normal kidney or renal ce］i carcinoma． Activity remaining is
         expressed as the percentage of va］ue for untreated control．
，〈：一一ta一一一一一一一一一一一一・一一一一ny”一一・・一一
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          low grade hlgh grade
Grade of malignancy and Al． P－ase activity
in renal cell carcinoma （RCC） tissue．
Fig． 5．
c＊  ＊＊m g＊＊＊
Cell type and Al． P－ase activity in renal
c ll carcinoma （RCC） tissue．
  ＊ clear cell type．
＊＊ mixed cell type．
＊＊＊ granular cell type．
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Table 5． lsozyme pattern of Al． P－ase in
     renal cell carcinoma by polyacryl－
     amide gcユdisk electrophoresis．






































 ’ lsozyime．detgcted ［rom K3 to K4 regton， but the
 separation is not enougfi to identify as K3 er K4．
M lsozyme not detected ±n normal renal tissue． Ko
 i［ioves faster than Kl and Ks slowor than K4．
”★エs。zy皿e detecセ・d b・tween Kl・・d K2（K1－K2〕。・K2・・d















   について
 i． Kasahara isozyme










































































liver type Al． P－ase detected in
RCC tissue （patient No． 24）．
liver type Al． P－ase and Kasahara
isozyme detected in RCC tissue
（patient No． 16）．
bone type Al． P－ase detected in
RCC tissue （patient No． 9）．
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Fig． 7． 1 and 5： normal liver Al． P－ase as a controL
     2：
3：
4：
liver type Al． P－ase detected in
RCC tissue （patient No． 24）．
enzy皿e preparation of patient No．
24 after the treatment with neura－
minidase．
enzyme preparation of normal liver
after the treatment with neura－
minidase．
3灘麟









Fig． 8 1： normal liver Al． P－ase as a control．
    2： enzyme preparation of RCC tissue from
     patient No． 23． The electrophoretic
     mobility of the main component of the
     enzyme is sUcr．hly slower than the normal
     liver AL P－ase．
    3： enzyme preparation from patient No． 23














































































































































































































Fig． 9．Histological examination of the liver biopsy specimen from the RCC patient with
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